(S)-1-((11bS,12S,14aR)-13-methoxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-yl)4-methyl 2-(4-acetoxybenzyl)succinate

ID: ALA5270945

Chembl Id: CHEMBL5270945

Max Phase: Preclinical

Molecular Formula: C32H35NO9

Molecular Weight: 577.63

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)C[C@H](Cc1ccc(OC(C)=O)cc1)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4

Standard InChI:  InChI=1S/C32H35NO9/c1-19(34)41-23-7-5-20(6-8-23)13-22(15-28(35)38-3)31(36)42-30-27(37-2)17-32-10-4-11-33(32)12-9-21-14-25-26(40-18-39-25)16-24(21)29(30)32/h5-8,14,16-17,22,29-30H,4,9-13,15,18H2,1-3H3/t22-,29+,30+,32-/m0/s1

Standard InChI Key:  GSLCHBBQRVVTGH-ZIYPCBBUSA-N

Alternative Forms

  1. Parent:

    ALA5270945

    ---

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 577.63Molecular Weight (Monoisotopic): 577.2312AlogP: 3.69#Rotatable Bonds: 8
Polar Surface Area: 109.83Molecular Species: BASEHBA: 10HBD: 0
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.42CX LogP: 3.22CX LogD: 1.21
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.34Np Likeness Score: 1.42

References

1. Yang Y, Yu Q, Hu L, Dai B, Qi R, Chang Y, Zhang Q, Zhang Z, Li Y, Zhang X..  (2022)  Enantioselective semisynthesis of novel cephalotaxine esters with potent antineoplastic activities against leukemia.,  244  [PMID:36242991] [10.1016/j.ejmech.2022.114731]

Source